Normal Reference Range for Hepatitis C Virus (HCV) Quantitative Testing
Apr 14, 2022
Source: Cainiu Health
Dr. Jin Zhongkui
Introduction
The normal reference range for hepatitis C virus (HCV) quantitative testing is: high-sensitivity assay <15 IU/mL; standard assay <1 × 10³ IU/mL. HCV viral load is closely associated with HCV replication activity, disease prognosis, and response to antiviral therapy. The day before blood collection, patients should avoid consuming overly fatty foods and alcohol. Fasting is required after 8:00 PM on the evening prior to blood draw.
Many men and women undergo routine annual physical examinations at hospitals to monitor their overall health. Among these tests, hepatitis C virus (HCV) quantitative testing helps assess one’s health status. What is the normal reference range for HCV viral load?
What Is the Normal Reference Range for Hepatitis C Virus Quantitative Testing?
The normal reference range for HCV quantitative testing is “undetectable” using high-sensitivity assays (<15 IU/mL). Standard assays typically report results as “undetectable” below 1 × 10³ IU/mL. The HCV viral load correlates closely with viral replication activity, disease prognosis, and response to antiviral therapy. To ensure accurate test results, patients should avoid consuming overly fatty foods and alcohol the day before blood collection. Fasting is required after 8:00 p.m. the night before the test, and patients should remain relaxed—stress or dietary noncompliance may affect test outcomes.
Upon diagnosis of hepatitis C infection, patients should seek prompt medical evaluation and treatment. Hepatitis C is a curable disease. Current treatments achieve cure rates exceeding 99%. Historically, interferon combined with ribavirin was the standard antiviral regimen; while many patients achieved sustained virologic response (SVR), others could not tolerate prolonged treatment duration or significant interferon-related side effects.
Today, hepatitis C treatment has become significantly simpler. Oral direct-acting antiviral (DAA) regimens require only approximately three months of therapy, cause minimal side effects, and are highly convenient to administer. Most patients tolerate these regimens well, and cure rates remain exceptionally high. We hope this information proves helpful to you.
